Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis

PURPOSE: To understand the functional and preclinical efficacy of targeting urokinase plasminogen activator receptor (u-PAR) in ovarian cancer. EXPERIMENTAL DESIGN: Expression of u-PAR was studied in 162 epithelial ovarian cancers, including 77 pairs of corresponding primary and metastatic tumors. T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kenny, Hilary A., Leonhardt, Payton, Ladanyi, Andras, Yamada, S. Diane, Montag, Anthony, Im, Hae Kyung, Jagadeeswaran, Sujatha, Shaw, David E., Mazar, Andrew P., Lengyel, Ernst
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3073583/
https://ncbi.nlm.nih.gov/pubmed/21149615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2258
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares